Thursday, 6 February 2014

Science: Cancer Immunotherapy breakthrough therapy of the year 2013!

The scientific journal  Science  has selected Cancer Immunotherapy as breakthrough therapy of the year 2013.

Patients with metastatic Melanoma will be familiar with the drugs- like Ipilimumab, Nivolumab and other CTL4, PD1 and PDL1 antibodies- that make use of the body's own immune system to attack the cancer and that for the first time are able to provide long-term survival in Melanoma.

Read the full article under:

No comments:

Post a Comment